PTGX
Protagonist Therapeutics IncNASDAQHEALTHCAREBIOTECHNOLOGY
Key Statistics
Market Cap
$6.38B
P/E Ratio
—
EPS
$-1.81
Beta
1.88
52W High
$107.84
52W Low
$45.28
50-Day MA
$101.25
200-Day MA
$83.24
Dividend Yield
—
Profit Margin
-154.90%
Forward P/E
21.01
PEG Ratio
0.00
About Protagonist Therapeutics Inc
Protagonist Therapeutics, Inc., a clinical-stage biopharmaceutical company, discovers and develops peptide-based therapeutic drugs to address unmet medical needs. The company is headquartered in Newark, California.
Fundamentals
| Revenue (TTM) | $74.06M |
| Gross Profit (TTM) | $74.06M |
| EBITDA | $-141.02M |
| Operating Margin | -6.47% |
| Return on Equity | -17.10% |
| Return on Assets | -12.40% |
| Revenue/Share (TTM) | $1.16 |
| Book Value | $10.21 |
| Price-to-Book | 9.73 |
| Price-to-Sales (TTM) | 86.13 |
| EV/Revenue | 78.83 |
| EV/EBITDA | 244.64 |
| Quarterly Earnings Growth (YoY) | 351.30% |
| Quarterly Revenue Growth (YoY) | 99.00% |
| Shares Outstanding | $64.31M |
| Float | $52.49M |
| % Insiders | 0.71% |
| % Institutions | 125.22% |
Historical Volatility
HV 10-Day
47.30%
HV 20-Day
44.07%
HV 30-Day
43.82%
HV 60-Day
44.62%
HV Rank
67.5%
Volatility is currently expanding
Analyst Ratings
Consensus ($118.69 target)
3
Strong Buy8
Buy1
HoldMore HEALTHCARE Stocks
Data last updated: 5/25/2026